Not applicableEnded earlyNCT05421533What this trial is testingStudy in Atrial Fibrillation (AF) Patients at High Risk of StrokeWho this might be right forAtrial Fibrillation Anthos Therapeutics, Inc. 705
Large-scale testing (Phase 3)Study completedNCT01877915What this trial is testingAssess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart FailureWho this might be right forHeart FailureCoronary Artery Disease Janssen Research & Development, LLC 5,081
Large-scale testing (Phase 3)Study completedNCT03395639What this trial is testingEdoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac DiseaseWho this might be right forCardiac Disease Daiichi Sankyo 168
Post-approval studies (Phase 4)Study completedNCT02666742What this trial is testingDOACs for Stroke Prevention Post Ventricular Tachycardia AblationWho this might be right forVentricular TachycardiaPremature Ventricular ContractionStroke Kansas City Heart Rhythm Institute 246
Not applicableLooking for participantsNCT07822737What this trial is testingPCCT-Defined High-Risk Plaque and Future Coronary Events: The PREDICT StudyWho this might be right forCoronary Artery DiseasePlaquePhoton-Counting Computed Tomography Beijing Chao Yang Hospital 500
Not applicableNot Yet RecruitingNCT07374718What this trial is testingSafety and Efficacy of De-escalation Dual Antiplatelet Therapy After BioFreedom™ Stenting in ACS Patients With Moderate-to-high Ischemic and High Bleeding RiskWho this might be right forAcute Coronary Syndrome (ACS)High Bleeding Risk(HBR)Coronary Artery Disease (CAD) Shenyang Northern Hospital 468
Not applicableEnrolling By InvitationNCT07625488What this trial is testingMeasuring Athlete's Risk of Cardiovascular Events 3 (MARC-3)Who this might be right forCoronary Artery DiseaseAtherosclerosis Radboud University Medical Center 250
Post-approval studies (Phase 4)Ended earlyNCT01959425What this trial is testingOral Anticoagulation Therapy Pilot StudyWho this might be right forParoxysmal Atrial Fibrillation Biosense Webster, Inc. 80
Not applicableLooking for participantsNCT06939985What this trial is testingCardiometabolic evalUation REgistry of Heart FailureWho this might be right forHeart FailureMetabolic Cardiovascular SyndromeMetabolic Diseases Ruijin Hospital 5,000
Not applicableUnknownNCT04330287What this trial is testingHIV-HEART Aging StudyWho this might be right forHIV InfectionsCoronary DiseaseMyocardial Infarction+4 more University Hospital, Essen 2,000
Large-scale testing (Phase 3)Study completedNCT00190593What this trial is testingRaloxifene Use for The HeartWho this might be right forCardiovascular DiseasesBreast Neoplasms Eli Lilly and Company 10,000
Large-scale testing (Phase 3)Ended earlyNCT01975389What this trial is testingThe Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk SubjectsWho this might be right forCardiovascular Disease Pfizer 10,564
Testing effectiveness (Phase 2)UnknownNCT04182594What this trial is testingCardiovascular Events in GnRH Agonist vs. AntagonistWho this might be right forHormone Sensitive Prostate CancerProstate CancerCardiac Event Rabin Medical Center 80
Large-scale testing (Phase 3)Looking for participantsNCT06307652What this trial is testingStudy to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney FunctionWho this might be right forHeart Failure and Impaired Kidney Function AstraZeneca 3,850
Not applicableStudy completedNCT00753233What this trial is testingIdentification of Risk Factors for Arrhythmia in Children and Adolescents With Hypertrophic CardiomyopathyWho this might be right forHypertrophic Cardiomyopathy (HCM) National Heart, Lung, and Blood Institute (NHLBI) 145
Not applicableActive Not RecruitingNCT06902857What this trial is testingStudy on the Predictive Value of High-sensitivity Cardiac Troponin I, N-terminal Pro-B-natriuretic Peptide, and Soluble Suppression of Tumorigenesis-2 for Mortality and the Development of Cardiovascular Events in Patients With Type 2 Diabetes (Diabetes-CV)Who this might be right forType 2 DiabetesCardiovascular Complication Istituto Nazionale di Ricovero e Cura per Anziani 964
Not applicableStudy completedNCT06029777What this trial is testingPeri-luminal COROnary CTa AI-driven radiOMICS to Identify Vulnerable Patients (CORO-CTAIOMICS)Who this might be right forCoronary Artery Disease IRCCS San Raffaele 2,190
Not applicableStudy completedNCT00512109What this trial is testingVascular Events In Noncardiac Surgery Patients Cohort Evaluation Study (VISION)Who this might be right forVascular DeathMyocardial InfarctionCardiac Arrest+1 more McMaster University 40,060
Large-scale testing (Phase 3)Study completedNCT01586975What this trial is testingAspirin Resistance and Stroke Risk: Platelet Function Analysis in Patients With Ischemic EventsWho this might be right forStrokeMyocardial Infarctions Northwestern University 93
Not applicableUnknownNCT01589536What this trial is testingSocial Medical Progression of Coronary Heart Disease With Associated Psychosocial Comorbidity -Interval Rehabilitation.Who this might be right forCardiovascular Events Clinic Roderbirken 480